Home/Filings/4/0001209191-23-013301
4//SEC Filing

Rona Jeffrey A 4

Accession 0001209191-23-013301

CIK 0001636651other

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 5:24 PM ET

Size

5.4 KB

Accession

0001209191-23-013301

Insider Transaction Report

Form 4
Period: 2023-02-23
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-23+175,000175,000 total
    Exercise: $2.50Exp: 2033-02-22Common Stock (175,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on February 23, 2024 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001311404

Filing Metadata

Form type
4
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:24 PM ET
Size
5.4 KB